Literature DB >> 10910369

Elevated mortality rates from circulatory disease in African American men and women of Los Angeles County, California--a possible genetic susceptibility?

S O Henderson1, G A Coetzee, R K Ross, M C Yu, B E Henderson.   

Abstract

OBJECTIVE: Reports of higher mortality in African Americans have often focused on socioeconomic differences. Such differences do not explain the excess mortality in African Americans compared with Hispanics in Los Angeles County. We suggest the existence of genetic factors to explain at least some of the differences in mortality risk.
METHODS: We compared the mortality rates from circulatory diseases in African American and Hispanic adults of Los Angeles County for 1988 to 1992 with the frequency of the angiotensin-converting enzyme (ACE) genotype.
RESULTS: African American adults 45 to 74 years old had a 2-fold higher overall mortality rate than Hispanics. The largest differences were seen for hypertensive disease and cardiomyopathy in men; the most striking differences were seen in the youngest age group. Rates were lower in women than in men, but African American women also showed substantial excess compared with Hispanics. ACE genotype also showed a significant difference between the Hispanic and African American population; the latter had a significantly higher prevalence of the DD genotype, which is associated with a higher level of circulating enzyme, and lower prevalence of the II genotype, which is associated with a lower enzyme level.
CONCLUSION: African American adults aged 45 to 74 years in Los Angeles County have a substantial excess mortality from hypertensive diseases compared with a similar Hispanic population. The frequency of the ACE DD genotype was higher in African Americans than in Hispanics. These studies may indirectly support the possibility of a genetic contribution to the excess hypertensive disease mortality in African Americans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910369     DOI: 10.1097/00000441-200007000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Treatment of hypertension in African Americans and Latinos: the effect of JNC VI on urban prescribing practices.

Authors:  Sean O Henderson; Philip Bretsky; Vincent DeQuattro; Brian E Henderson
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Mar-Apr       Impact factor: 3.738

Review 2.  Ethnic Differences in Oral Antithrombotic Therapy.

Authors:  Haechan Cho; Jeehoon Kang; Hyo Soo Kim; Kyung Woo Park
Journal:  Korean Circ J       Date:  2020-08       Impact factor: 3.243

3.  Established risk factors account for most of the racial differences in cardiovascular disease mortality.

Authors:  Sean O Henderson; Christopher A Haiman; Lynne R Wilkens; Laurence N Kolonel; Peggy Wan; Malcolm C Pike
Journal:  PLoS One       Date:  2007-04-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.